David Kerr (oncologist)
David James Kerr CBE, MA MD DSc FRCP (Glas & Lon) FRCGP (Hon) FMedSci | |
|---|---|
| Born | 1956 Glasgow, Scotland |
| Nationality | British |
| Education | University of Glasgow –DSC(1996) PhD (1990)MSc(1990) MD (1987),MBChB (1980)
BScBiochemistry (1977)= University of Oxford - MA (2002) |
| Years active | 1992-present |
| Known for | Research and Treatment of colorectal cancer; Gene Therapy |
| Medical career | |
| Profession | Medical Doctor, researcher |
| Field | Oncology |
| Institutions | Oxford University |
| Research | Colorectal Cancer, Gene Therapy |
| Awards |
|
Professor David James Kerr CBE (born 1956, Glasgow) is a British Cancer Researcher. His primary area of research is treatment and management of colorectal cancer.
He served as Chief Research Advisor at Sidra Medical and Research Center in Doha, Qatar. David James Kerr is Professor of Cancer Medicine and Former Fellow of Corpus Christi College, Oxford. He was also President-Elect for European Society for Medical Oncology (2009).
David James Kerr’s clinical research into adjuvant therapy of early-stage colorectal cancer has contributed to saving thousands of lives over the past two decades.